FitLife Brands Holds on to Analyst Confidence Amid Mixed Sales and Online Strength

FitLife Brands, Inc. (NASDAQ:FTLF) is one of the 13 Best Low Risk High Growth Stocks to Buy.

Analysts stick to their Buy rating on the stock amid mixed first-quarter results for 2025.

FitLife Brands, Inc. (NASDAQ:FTLF) is a developer and marketer of nutritional supplements. Based in Nebraska, the company targets weight loss, sports nutrition, and general wellness with its supplements. Its portfolio spans proprietary brands like NDS Nutrition, PMD Sports, SirenLabs, Nutrology, Dr. Tobias, and MusclePharm. In addition to retail channels, the company is notably active on online channels across the globe.

On May 15, 2025, the company announced its Q1 2025 earnings results. The results indicated an uptick of 5% in the total revenue of its brand Legacy FitLife, contributed by the 11% increase in online revenue and a 2% increase in wholesale revenue. On the other hand, the company’s total revenue for the quarter saw a 4% decline compared to the same quarter the previous year, owing to a fall in sales in other brands like Mimi’s Rock and MusclePharm.

Despite the mixed results, analysts like Lake Street and Roth MKM maintained their Buy rating on the stock, with a price target of $21.00 and $20.00, respectively.

FitLife Brands, Inc. (NASDAQ:FTLF) has a volatility indicated by its beta of 0.80 and an attractive EPS growth of 20.44% anticipated in the next 5 years, creating a balance between risk and reward.

While we acknowledge the potential of FTLF as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Metal Stocks with Insider Buying in 2025 and 10 Energy Stocks with Insider Buying in 2025

Disclosure. None.